Company Overview
Snapshot
Founded in January 2021 by Gideon Barak and Shani Toledano, HT Vet operates with 11–50 employees. The company has raised $1M across two funding rounds. In May 2026, HT Vet secured a grant from the BIRD Foundation.
Business overview
HT Vet is a Health Tech & Life Sciences company focused on developing AI-driven solutions for the early diagnosis of cancer in pets. Its core product, HT Vista, is an AI-driven non-invasive screening tool that utilizes Heat Diffusion Imaging (HDI) technology and cloud-based analysis to enable veterinarians and nurses to rule out dermal and subcutaneous masses in dogs on-the-spot. The company aims to empower clinicians with quick and confident cancer diagnoses, serving the veterinary industry globally with a B2B2C and B2B business model.
Strategic signal
In May 2026, HT Vet secured a grant from the BIRD Foundation, indicating external validation and support for its innovative AI-driven diagnostic technology. This grant suggests a positive outlook for the company's continued development and potential market expansion, reinforcing investor confidence in its strategic direction and technological capabilities.
Log in to access full profile ›Company Intelligence Q&A
- What is HT Vet's primary focus?
- HT Vet develops AI-driven non-invasive screening tools for the early diagnosis of cancer in pets, specifically targeting dermal and subcutaneous masses in dogs.
- When was HT Vet founded and by whom?
- HT Vet was founded in January 2021 by Gideon Barak and Shani Toledano.
- What is the HT Vista device?
- The HT Vista device is an AI-driven non-invasive screening tool that uses Heat Diffusion Imaging (HDI) technology and cloud-based analysis to help veterinarians and nurses rule out cancer in dogs on-the-spot.
- What was a significant recent development for HT Vet?
- In May 2026, HT Vet secured a grant from the BIRD Foundation, supporting its ongoing projects.
- What new service did HT Vet's Vista IQ introduce in January 2026?
- In January 2026, HT Vet's Vista IQ introduced a new cancer diagnostic service, projected to unlock $130,000 in annual revenue for veterinary clinics.